Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders

Archives of Neurology

Volumn 56, Issue 8, 1999, Pages 919-926

  Rudkin, Teresa M ^a   Arnold, Douglas L ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHORUS; PROTON;

BRAIN TUMOR; CEREBROVASCULAR DISEASE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; EPILEPSY; HISTORY; HUMAN IMMUNODEFICIENCY VIRUS 1; MAGNETISM; METABOLIC DISORDER; MULTIPLE SCLEROSIS; PATIENT CARE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0032839657     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.8.919     Document Type: Conference Paper

References (31)

1. Mourino MR. From Thales to Lauterbur, or from the lodestone to MR imaging: magnetism and medicine. Radiology. 1991;180:593-612.
2. Matthews PM, Francis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis [published correction appears in Neurology. 1991;41:1828]. Neurology. 1991;41:1251-1256.
3. van der Knaap MS, van der Grond J, van Rijen PC, Faber JA, Valk J, Willemse K. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology. 1990;176: 509-515.
4. Kato T, Nishina M, Matsushita K, Hori E, Mito T, Takashima S. Neuronal maturation and N-acetyl-L-aspartic acid development in human fetal and child brains. Brain Dev. 1997;19:131-133.
5. Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med. 1996;2:323-325.
6. Preul MC, Caramanos Z, Leblanc R, Villemure JG, Arnold DL. Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors. NMR Biomed. 1998;11:192-200.
7. Cendes F, Caramanos Z, Andermann F, Dubeau F, Arnold DL. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Ann Neurol. 1997;42:737-746.
8. Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy: evidence from proton MR spectroscopic imaging. Neurology. 1997;49:1525-1533.
9. Vargha-Khadem F, Gadian DG, Watkins KE, Connelly A, Van Paesschen W, Mishkin M. Differential effects of early hippocampal pathology on episodic and semantic memory [published correction appears in Science. 1997;277:1117]. Science. 1997;277:376-380.
10. Arnold DL, Matthews PM, Francis GS, O'Connor J, Antel JP. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol. 1992;31:235-241.
11. 1H spectroscopic imaging. Ann Neurol. 1994; 36:157-165.
12. Waxman SG. Demyelinating diseases: new pathological insights, new therapeutic targets. N Engl J Med. 1998;338:323-325.
13. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain. 1997;120(pt 3):393-399.
14. Matthews PM, De Stefano N, Narayanan S, et al. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in mulitple sclerosis. Semin Neurol. 1998;18:327-336.
15. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain. 1994;117(pt 1): 49-58.
16. Narayana PA, Doyle TJ, Lai D, Wolinsky JS. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol. 1998;43:56-71.
17. Fu L, Matthews PM, De Stefano N, et al. Imaging axonal damage of normal appearing white matter in multiple sclerosis. Brain. 1998;121:103-113.
18. Chang L. In vivo magnetic resonance spectroscopy in HIV and HIV-related brain diseases. Rev Neurosci. 1995;6:365-378.
19. Wilkinson ID, Lunn S, Miszkiel KA, et al. Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS. J Neurol Neurosurg Psychiatry. 1997; 63:477-482.
20. Holshouser BA, Ashwal S, Luh GY, et al. Proton MR spectroscopy after acute central nervous system injury: outcome prediction in neonates, infants, and children. Radiology. 1997;202:487-496.
21. Saunders DE, Howe FA, Van den Boogaart A, et al. Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke. 1995;26:1007-1013.
22. Graham GD, Kalvach P, Blamire AM, Brass LM, Fayad PB, Prichard JW. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke. 1995;26:225-229.
23. Uno M, Ueda S, Hondo H, Matsumoto K, Harada M. Effectiveness of revascularization surgery evaluated by proton magnetic resonance spectroscopy and single photon emission computed tomography. Neurologia Med Chir (Tokyo). 1996; 36:560-566.
24. Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology. 1994;44:1933-1938.
25. Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport. 1998;9:1757-1761.
26. Schuft N, Amend D, Ezekiel F, et al. Changes of hippocampal N-acetylaspartate and volume in Alzheimer's disease: a proton MR spectroscopic imaging and MRI study. Neurology. 1997;49:1513-1521.
27. Holshouser BA, Komu M, Moller HE, et al. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study. Magn Resort Med. 1995;33: 589-594.
28. 1H NMR spectroscopy. Neurology. 1993;43:2689-2695.
29. Laubenberger J, Haussinger D, Bayer S, Gufler H, Hennig J, Langer M. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology. 1997;112:1610-1616.
30. Frahm J, Hanefeld F. Localized proton magnetic resonance spectroscopy of brain disorders in childhood. In: Bachelard HS, ed. Advances in Neurochemistry. London, England: Plenum Press; 1998: 330-402.
31. Grodd W, Krageloh-Mann I, Klose U, Sauter R. Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. Radiology. 1991;181:173-181.